Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Xalkori (crizotinib) - Important Safety Information from Pfizer Healthcare Ireland as approved by the HPRA
Notice type:
3rd Party Publications
Date:
15/10/2015
Problem Or Issue:
Important Safety Information communication from Pfizer Healthcare Ireland on the inclusion of a new warning regarding cardiac failure associated with Xalkori (crizotinib).
Important Safety Information - Xalkori (crizotinib)
« Back
Date Printed: 18/04/2024